153 related articles for article (PubMed ID: 3509884)
1. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats.
Zwahlen A; Rubin LG; Moxon ER
Microb Pathog; 1986 Oct; 1(5):465-73. PubMed ID: 3509884
[TBL] [Abstract][Full Text] [Related]
2. Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats.
Zwahlen A; Winkelstein JA; Moxon ER
J Infect Dis; 1983 Sep; 148(3):385-94. PubMed ID: 6604759
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the cell wall of Haemophilus influenzae type b by transformation with cloned DNA: association with attenuated virulence.
Zwahlen A; Rubin LG; Connelly CJ; Inzana TJ; Moxon ER
J Infect Dis; 1985 Sep; 152(3):485-92. PubMed ID: 3875666
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap.
Zwahlen A; Kroll JS; Rubin LG; Moxon ER
Microb Pathog; 1989 Sep; 7(3):225-35. PubMed ID: 2615636
[TBL] [Abstract][Full Text] [Related]
5. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants.
Moxon ER; Vaughn KA
J Infect Dis; 1981 Apr; 143(4):517-24. PubMed ID: 6972419
[TBL] [Abstract][Full Text] [Related]
6. Participation of complement in host defense against capsule-deficient Haemophilus influenzae.
Zwahlen A; Winkelstein JA; Moxon ER
Infect Immun; 1983 Nov; 42(2):708-15. PubMed ID: 6605926
[TBL] [Abstract][Full Text] [Related]
7. Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae.
Weiser JN; Williams A; Moxon ER
Infect Immun; 1990 Oct; 58(10):3455-7. PubMed ID: 2401571
[TBL] [Abstract][Full Text] [Related]
8. Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.
Cope LD; Yogev R; Mertsola J; Argyle JC; McCracken GH; Hansen EJ
Infect Immun; 1990 Jul; 58(7):2343-51. PubMed ID: 1694825
[TBL] [Abstract][Full Text] [Related]
9. Intra- and interstrain differences of virulence among nontypeable Haemophilus influenzae strains.
Melhus A; Hermansson A; Forsgren A; Prellner K
APMIS; 1998 Sep; 106(9):858-68. PubMed ID: 9808412
[TBL] [Abstract][Full Text] [Related]
10. Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence.
Moxon ER; Deich RA; Connelly C
J Clin Invest; 1984 Feb; 73(2):298-306. PubMed ID: 6607932
[TBL] [Abstract][Full Text] [Related]
11. Comparative virulence of Haemophilus influenzae with a type b or type d capsule.
Roberts M; Stull TL; Smith AL
Infect Immun; 1981 May; 32(2):518-24. PubMed ID: 6972914
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of invasive Haemophilus influenzae type b disease.
Moxon ER
J Infect Dis; 1992 Jun; 165 Suppl 1():S77-81. PubMed ID: 1588186
[TBL] [Abstract][Full Text] [Related]
13. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media.
Bouchet V; Hood DW; Li J; Brisson JR; Randle GA; Martin A; Li Z; Goldstein R; Schweda EK; Pelton SI; Richards JC; Moxon ER
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8898-903. PubMed ID: 12855765
[TBL] [Abstract][Full Text] [Related]
14. Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae.
Moxon ER; Kroll JS
Vaccine; 1988 Apr; 6(2):113-5. PubMed ID: 3291448
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variation in Haemophilus influenzae: the interrelationship of colony opacity, capsule and lipopolysaccharide.
Roche RJ; Moxon ER
Microb Pathog; 1995 Feb; 18(2):129-40. PubMed ID: 7643742
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Haemophilus influenzae type b lipopolysaccharide to pathogenesis of infection.
Kaplan SL; Hawkins EP; Inzana TJ; Patrick CC; Mason EO
Microb Pathog; 1988 Jul; 5(1):55-62. PubMed ID: 3072463
[TBL] [Abstract][Full Text] [Related]
17. Virulence of non-beta-lactamase-mediated ampicillin-resistant Haemophilus influenzae.
Rubin LG; Mendelman PM; Rakita RM; Rosen H
FEMS Microbiol Lett; 1991 Nov; 68(1):27-31. PubMed ID: 1769551
[TBL] [Abstract][Full Text] [Related]
18. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
Yogev R; Moxon ER
J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Haemophilus influenzae tehB gene and its role in virulence.
Whitby PW; Seale TW; Morton DJ; VanWagoner TM; Stull TL
Microbiology (Reading); 2010 Apr; 156(Pt 4):1188-1200. PubMed ID: 20075041
[TBL] [Abstract][Full Text] [Related]
20. Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.
Kapogiannis BG; Satola S; Keyserling HL; Farley MM
Clin Infect Dis; 2005 Dec; 41(11):e97-103. PubMed ID: 16267724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
